Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (401-410 of 443) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|August 14, 2024
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMTRazan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, et al.
Bone Marrow Transplantation|July 7, 2023
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Ioanna Sakellari, Myriam Labopin, et al.
Hemasphere|January 26, 2023
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMTAlexandros Spyridonidis, Myriam Labopin, Bipin Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2022
Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT AnalysisArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Transplantation and Cellular Therapy|July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAnnalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Blood Advances|May 26, 2018
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?Tara M Robinson, Ephraim J Fuchs, Mei-Jie Zhang, et al.
Bone Marrow Transplantation|December 23, 2022
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry StudyMohamad Mohty, Didier Blaise, Régis Peffault de Latour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationKarina Tozatto-Maio, Federica Giannotti, Myriam Labopin, et al.
Haematologica|June 19, 2025
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated <i>versus</i> haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationLin Li, Yishan Ye, Jacques-Emmanuel Galimard, et al.
Blood Advances|May 13, 2020
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantationMonzr M Al Malki, Dongyun Yang, Myriam Labopin, et al.
Pageof 45

Showing results (401-410 of 443) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|August 14, 2024
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMTRazan Mohty, Abdul Hamid Bazarbachi, Myriam Labopin, et al.
Bone Marrow Transplantation|July 7, 2023
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Ioanna Sakellari, Myriam Labopin, et al.
Hemasphere|January 26, 2023
Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMTAlexandros Spyridonidis, Myriam Labopin, Bipin Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2022
Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT AnalysisArnon Nagler, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Transplantation and Cellular Therapy|July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAnnalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Blood Advances|May 26, 2018
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?Tara M Robinson, Ephraim J Fuchs, Mei-Jie Zhang, et al.
Bone Marrow Transplantation|December 23, 2022
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry StudyMohamad Mohty, Didier Blaise, Régis Peffault de Latour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 26, 2018
Cord Blood Unit Dominance Analysis and Effect of the Winning Unit on Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults with Acute Leukemia: A Retrospective Study on Behalf of Eurocord, the Cord Blood Committee of Cellular Therapy, Immunobiology Working Party, and the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationKarina Tozatto-Maio, Federica Giannotti, Myriam Labopin, et al.
Haematologica|June 19, 2025
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated <i>versus</i> haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationLin Li, Yishan Ye, Jacques-Emmanuel Galimard, et al.
Blood Advances|May 13, 2020
Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantationMonzr M Al Malki, Dongyun Yang, Myriam Labopin, et al.
Pageof 45